Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine Effects on Metabolic Syndrome (GALANTA-MS)
NCT02283242Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Mar 2014
- Primary completion
- Mar 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of galantamine in metabolic syndrome, sponsored by Universidade de São Paulo. Started Mar 2014; status: completed.
02
Drugs
galantamine
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT02283242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02283242.